Literature DB >> 8070447

The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary.

G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8070447     DOI： 10.1007/bf01971991

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  21 in total

1.  Modulation of functions of granulocytes by recombinant human GM-CSF and possible complications of GM-CSF therapy.

Authors:  M Klausmann; K H Pflüger; D Krumwieh; F R Seiler; K Havemann
Journal:  Leukemia       Date:  1988-12       Impact factor: 11.528

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

Review 3.  Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

Authors:  E Anaissie
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

4.  Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo.

Authors:  I E Addison; B Johnson; S Devereux; A H Goldstone; D C Linch
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome.

Authors:  B S Bender; J F Bohnsack; S H Sourlis; M M Frank; T C Quinn
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 6.  The use of GM-CSF in AIDS.

Authors:  D T Scadden
Journal:  Infection       Date:  1992       Impact factor: 3.553

7.  Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.

Authors:  G C Baldwin; J C Gasson; S G Quan; J Fleischmann; R Weisbart; D Oette; R T Mitsuyasu; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.

Authors:  J Nemunaitis; S N Rabinowe; J W Singer; P J Bierman; J M Vose; A S Freedman; N Onetto; S Gillis; D Oette; M Gold
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

9.  Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer.

Authors:  G P Bodey; E Anaissie; J Gutterman; S Vadhan-Raj
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

10.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

Authors:  A Schaffner; H Douglas; A Braude
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808
View more
  2 in total

1.  Role of granulocyte colony-stimulating factor in the treatment of mucormycosis.

Authors:  B Sahin; S Paydaş; E Coşar; K Biçakçi; B Hazar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

2.  Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.

Authors:  Hongtao Kang; Yinglin Qi; Hualei Wang; Xuexing Zheng; Yuwei Gao; Nan Li; Songtao Yang; Xianzhu Xia
Journal:  Viruses       Date:  2015-03-11       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.